Bechiri SRL
1.3 FTEThe score of Bechiri shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +11 % Total assets +12 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bechiri's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 50,155 € | ||||
| Equity | 301,218 € | ||||
| Cash | 40,937 € | ||||
| EBITDA | 71,408 € | ||||
| Total assets | 608,047 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 17 Jun 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Bechiri's financial analysis
- Solvency49.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bechiri
Bechiri's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0457.003.127
- VAT number
- BE0457003127
- Peppol
- Registered · 0208:0457003127 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Jan 1996
- Registered office
- 4750 Bütgenbach
- Size
- Micro · 1.3 FTE
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bechiri (SRL) has been based in Bütgenbach since 1996, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 50,155 € and equity of 301,218 €; its revenue is not published. With 1.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 49.5%, above the median of its sector (41.5%).
Companies similar to Bechiri
Companies in the same business, of comparable size and area, outside its group.
- Pharma Jack Retail sale of pharmaceutical products Charleroi · balance sheet 604,334 €
- Smith Pharma Retail sale of pharmaceutical products Willebroek · balance sheet 610,521 €
- Apotheek Winterslag Retail sale of pharmaceutical products Genk · balance sheet 604,173 €
- Vermunicht Retail sale of pharmaceutical products Hulshout · balance sheet 602,591 €
- Pharmacie DE LA Jonction Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 601,403 €
- Geassocieerde Apotheek Merksem Retail sale of pharmaceutical products Antwerp · balance sheet 623,918 €
- "Farminco" Retail sale of pharmaceutical products Andenne · balance sheet 589,804 €
- Pharmenform Retail sale of pharmaceutical products Koekelberg · balance sheet 567,837 €
Frequently asked questions about Bechiri
What is the revenue of Bechiri?
Bechiri files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bechiri?
In Belgium, the VAT number is the company number prefixed with BE: BE0457003127 for Bechiri, if the company is VAT-registered. Its company number (CBE) is 0457.003.127.
Where is the registered office of Bechiri?
According to the CBE register, the registered office of Bechiri is in 4750 Bütgenbach.
What is the equity of Bechiri?
At the close of the 2025 financial year, the equity of Bechiri amounts to 301,218 €, a solvency of 49.5% of total assets.
How many people work at Bechiri?
1.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Bechiri?
The register lists 1 active mandates at Bechiri. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bechiri
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →